Novozymes A/S
🇩🇰Denmark
- Country
- 🇩🇰Denmark
- Ownership
- Public, Subsidiary
- Established
- 2000-01-01
- Employees
- 6.7K
- Market Cap
- -
Clinical Trials
12
Active:0
Completed:10
Trial Phases
1 Phases
Not Applicable:12
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (12 trials with phase data)• Click on a phase to view related trials
Not Applicable
12 (100.0%)RCT: Enzyme Blend Toothpaste on Dental Biofilm Plaque Accumulation
Not Applicable
Completed
- Conditions
- Dental Biofilm Accumulation
- First Posted Date
- 2025-07-23
- Last Posted Date
- 2025-08-08
- Lead Sponsor
- Novozymes A/S
- Target Recruit Count
- 132
- Registration Number
- NCT07079683
- Locations
- 🇺🇸
Salus Research Inc, Fort Wayne, Indiana, United States
Effect of Enzyme-containing Lozenge on Dental Biofilm Formation, Composition and Functionality
Not Applicable
Completed
- Conditions
- Dental Biofilm Accumulation
- First Posted Date
- 2023-11-21
- Last Posted Date
- 2025-01-03
- Lead Sponsor
- Novozymes A/S
- Target Recruit Count
- 34
- Registration Number
- NCT06142409
- Locations
- 🇩🇰
Department of Dentistry and Oral Health, Aarhus University, Aarhus, Denmark
Effect of a Combination of Lactase and L. Salivarius DSM 34078 in Individuals With Lactose Intolerance
Not Applicable
Completed
- Conditions
- Lactose Intolerance
- First Posted Date
- 2023-10-30
- Last Posted Date
- 2024-07-16
- Lead Sponsor
- Novozymes A/S
- Target Recruit Count
- 76
- Registration Number
- NCT06107088
- Locations
- 🇩🇪
Analyze & Realize Study Center, Berlin, Germany
Clinical Study of the Effect of Two Experimental Lozenges on Oral Malodor After Single Use
Not Applicable
Completed
- Conditions
- Oral Malodor
- First Posted Date
- 2023-07-18
- Last Posted Date
- 2023-07-18
- Lead Sponsor
- Novozymes A/S
- Target Recruit Count
- 156
- Registration Number
- NCT05950529
- Locations
- 🇺🇸
Salus Research, Fort Wayne, Indiana, United States
Bacillus Velezensis DSM 33864 for Reduction of the Risk of Recurrent Clostridioides Difficile Infections
Not Applicable
Withdrawn
- Conditions
- Clostridium Difficile Infection Recurrence
- First Posted Date
- 2022-11-04
- Last Posted Date
- 2024-11-22
- Lead Sponsor
- Novozymes A/S
- Target Recruit Count
- 104
- Registration Number
- NCT05606159
- Locations
- 🇺🇸
Beaumont Hospital, Royal Oak, Michigan, United States
- Prev
- 1
- 2
- 3
- Next
News
No news found